Medicine News and Research

RSS

Study highlights the growing toll of parental substance use on American children

A large percentage of American children are growing up in households with at least one parent who uses alcohol or other drugs in problematic ways-raising the risk that those children will go on to do the same, a new study suggests.

13 May 2025

Advanced microscopy reveals how hormonal fluctuations shape the brain

Hormone levels fluctuate like the tides, ebbing and flowing according to carefully orchestrated cycles.

13 May 2025

Readers scrutinize federal cuts and medical debt

The recent KFF Health News article "Beyond Ivy League, RFK Jr.'s NIH Slashed Science Funding Across States That Backed Trump" (April 17) struck a nerve.

13 May 2025

Hormone FGF21 reverses fatty liver disease by signaling the brain

A pioneering research study published today in Cell Metabolism details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works primarily by signaling the brain to improve liver function.

13 May 2025

Radiomics reveals breast texture patterns associated with cancer risk

In one of the larger studies of its kind, researchers have identified six breast texture patterns that may be associated with increased cancer risk, according to a new study published today in Radiology, a journal of the Radiological Society of North America (RSNA).

13 May 2025

New treatment approach boosts survival rates for patients with aggressive, inherited breast cancers

A new treatment approach significantly improves survival rates for patients with aggressive, inherited breast cancers, according to Cambridge researchers.

13 May 2025

New light-based 3D printing technique advances tissue engineering

Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have developed a technique that could help advance treatments in tissue engineering.

13 May 2025

Pentoxifylline offers no survival benefit for severe alcohol-associated hepatitis

Severe alcohol-associated hepatitis (sAH) remains a highly lethal condition with limited therapeutic options. Characterized by rapid liver decompensation, sAH is often accompanied by acute kidney injury (AKI), a complication that substantially worsens prognosis.

13 May 2025

Flavan-3-ols in tea and chocolate can lower blood pressure

We might have another reason to enjoy our daily cup of tea or small piece of dark chocolate, as a new study from the University of Surrey has found that naturally occurring compounds called flavan-3-ols - found in cocoa, tea, apples and grapes - may improve blood pressure and the health of our blood vessels.

13 May 2025

Study reveals key differences in health risks between males and females

The results of an international study led by researchers from Queen Mary University of London's Precision Healthcare University Research Institute (PHURI) shed new light the underlying biological mechanisms which cause differences in health risks, symptoms and outcomes between males and females.

13 May 2025

New brain network discovery could revolutionize depression diagnosis

In a comprehensive Genomic Press Commentary published today, researchers have identified what could be the first reliable biomarker for depression risk, potentially transforming how this devastating condition is identified and treated.

13 May 2025

Multiple health conditions linked to higher depression risk

People with multiple long-term physical health conditions are at a significantly greater risk of developing depression, a study shows.

13 May 2025

Simple oral swab test could revolutionize IVF success rates

About 15 per cent of all couples of reproductive age are involuntarily childless. A major reason why so many need assisted reproduction is that nowadays more and more people are putting off starting a family.

13 May 2025

Early cardiovascular benefits of semaglutide seen within months in SELECT trial

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or obesity who have pre-existing cardiovascular disease but not diabetes, according to a secondary analysis of the landmark Semaglutide and Cardiovascular Outcomes (SELECT) trial from the same international author team being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain.

12 May 2025